Orthobiologics company Bioventus LLC has announced a published study has found that its latest generation EXOGEN Ultrasound Bone Healing System can indeed help surgeons ensure that patients are using the device. According to the December 5, 2016 news release, the study found that the Bioventus system improves patient compliance by 10%; overall compliance never fell below 76%. EXOGEN uses safe, effective low-intensity pulsed ultrasound (LIPUS) to help stimulate the body’s natural healing process.
“The study found that among 12, 984 patient data files analyzed, the patient compliance was 84%, while compliance with the previous generation EXOGEN device was 74%. In addition, incorporation of the calendar feature resulted in compliance never decreasing below 76% over the 6-month analysis period.”
“The researchers also analyzed 12 clinical trials on LIPUS where compliance was recorded. In eight of these clinical studies, where they met their end point, compliance was 88%. If the primary end point was unmet, compliance averaged 54%.”
“This study clearly shows a correlation between clinical effectiveness and compliance rates of more than 70%, ” said Neill Pounder, director, Project Management, Bioventus. “The work also revealed that use of the next generation EXOGEN device resulted in a measurable improvement in patient adherence, which may help to optimize clinical outcomes and fracture healing. LIPUS technology can make a difference if it used as directed.”
Neill Pounder commented to OTW, “The study showed the impact of user needs and insights in the design of medical devices. The impact of the calendar had a significant effect in maintaining patient engagement with their prescribed treatment.”
“The device is prescribed by the orthopaedic surgeon, but until now the hope was that the patient was following the treatment. This study has shown that the prescriber can be confident the patient is following their direction and using the EXOGEN device.”
